Opportunity for B.Pharm, B.Sc as Senior Analyst in HCL Technologies
Our employees are strongly encouraged to use their own initiative and to be flexible. They are given the freedom to shape their roles and to define areas of work that will benefit directly from their individual expertise. This democratic approach encourages open discussion and brings new ideas to the table, ultimately creating a startup advantage.
The startup advantage enables employees to view themselves as entrepreneurs and change makers. They take pride in their ideas delivering value to customers, thereby transforming the business landscape.
Post: Senior Analyst- 1
Amity is the leading education group of India with over 50000 students studying across 700 acres of hi-tech campus.
A fast growing Ethical Pharma Company operating since 2012. Marketing a wide range of high quality and affordable generic medicines,we offer a portfolio of product in Neurology & Psychiatry, Ortho, Cardio-diabetic, & Few General Products. We have made strategic investments and collaborations with leading pharmaceuticals manufacturers, having approvals from accredited regulatory bodies.
Established in 2005, Cian Health Care Pvt. Ltd. is an emerging pharmaceutical company based at Pune, Maharashtra, India. Cian means Commitment, Innovation, Aspiration & Nurturing Relationships. Cian is a WHO-GMP & ISO-9001:2008 certified transnational manufacturing company with a wide range of pharmaceutical, nutraceutical and food supplement products. Cian has a full fledged R & D and regulatory department. Cian has its own manufacturing facility at Roorkee (Uttarakhand) and is being upgraded as per U.K. MHRA norms, and one more plant is under development in Wai (Mahashatra). Cian has developed more than 300 formulations and 500 brands for domestic market under 12 different strategic business units (SBU). Cian is in process of rapid expansion of its global business and has registered and in process of registering around 200 molecules globally, also looking forward to register more innovative molecules in next two years, covering South East Asia, C.I.S., African and Latin American Countries.
